Literature DB >> 29018182

Role of Nitric Oxide Pathway in Development and Progression of Chronic Kidney Disease in Rats Sensitive and Resistant to its Occurrence in an Experimental Model of 5/6 Nephrectomy.

Marek Saracyn1,2, Katarzyna Czarzasta3, Marek Brytan4, Piotr Murawski5, Sławomir Lewicki6, Tomasz Ząbkowski7, Robert Zdanowski6, Agnieszka Cudnoch-Jędrzejewska2, Grzegorz Wiktor Kamiński1, Zofia Wańkowicz2.   

Abstract

BACKGROUND Understanding the mechanisms conditioning development of chronic kidney disease (CKD) is still a challenge. The aim of this study was to evaluate the activity of the intrarenal nitric oxide (NO) pathway in the context of sensitivity or resistance of different animal strains to the development and degree of renal failure. MATERIAL AND METHODS Two rat strains were used: Wistar (WR) and Sprague-Dawley rats (SDR) in a model of CKD - 5/6 nephrectomy. We assessed parameters of renal failure and expression of nitric oxide synthase (NOS) isoforms in renal cortex and medulla. RESULTS We did not observe renal failure in WR, and CKD developed in SDR with increase of creatinine and urea concentration as well as decrease of diuresis and glomerular filtration. In the renal cortex, baseline expression of NOS2 was higher in WR than in SDR. 5/6 nephrectomy resulted in reduction of NOS2 in both strains and NOS3 in WR. In the renal medulla, baseline NOS2 expression was higher in SDR, and nephrectomy resulted in its decrease only in SDR. Although baseline NOS3 expression was higher in SDR, the NOS3 expression after nephrectomy was higher in WR rats. CONCLUSIONS In model of CKD - 5/6 nephrectomy, SDR proved to be sensitive and WR resistant to development of CKD. The intrarenal activity of the nitric oxide pathway was the factor that differentiated both strains. This mechanism may be responsible for insensitivity of WR to development of renal failure in this model of CKD.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29018182      PMCID: PMC5649515          DOI: 10.12659/msm.903820

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  25 in total

1.  Protection against puromycin aminonucleoside-induced chronic renal disease in the Wistar-Furth rat.

Authors:  Aaron Erdely; Gary Freshour; Cheryl Smith; Kevin Engels; Jean L Olson; Chris Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2004-03-23

2.  Distribution of nitric oxide synthase in normal and cirrhotic human liver.

Authors:  Lance McNaughton; Lakshmi Puttagunta; Maria Angeles Martinez-Cuesta; Norm Kneteman; Irvin Mayers; Redwan Moqbel; Qutayba Hamid; Marek W Radomski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

Review 3.  Current concepts on the role of nitric oxide in portal hypertension.

Authors:  Liang Shuo Hu; Jacob George; Jian Hua Wang
Journal:  World J Gastroenterol       Date:  2013-03-21       Impact factor: 5.742

4.  DOCA/NaCl-induced chronic kidney disease: a comparison of renal nitric oxide production in resistant and susceptible rat strains.

Authors:  Aaron Erdely; Gary Freshour; You-Lin Tain; Kevin Engels; Chris Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2006-08-08

Review 5.  The identification of nitric oxide as endothelium-derived relaxing factor.

Authors:  Joseph Loscalzo
Journal:  Circ Res       Date:  2013-07-05       Impact factor: 17.367

6.  Protection of wistar furth rats from chronic renal disease is associated with maintained renal nitric oxide synthase.

Authors:  Aaron Erdely; Laszlo Wagner; Veronica Muller; Attila Szabo; Chris Baylis
Journal:  J Am Soc Nephrol       Date:  2003-10       Impact factor: 10.121

7.  Effects of voluntary wheel running on the kidney at baseline and after ischaemia-reperfusion-induced acute kidney injury: a strain difference comparison.

Authors:  Natasha C Moningka; Mark W Cunningham; Myrline Sterling; Crystal A West; Jill W Verlander; Byron P Croker; Joslyn Ahlgren; Linda Hayward; Chris Baylis
Journal:  J Physiol       Date:  2012-12-24       Impact factor: 5.182

8.  Nitric oxide mediates hepatocyte injury.

Authors:  J H Wang; H P Redmond; Q D Wu; D Bouchier-Hayes
Journal:  Am J Physiol       Date:  1998-11

9.  Minocycline attenuates oxidative/nitrosative stress and cerebral complications of acute liver failure in rats.

Authors:  Wenlei Jiang; Paul Desjardins; Roger F Butterworth
Journal:  Neurochem Int       Date:  2009-06-11       Impact factor: 3.921

10.  International Network of Chronic Kidney Disease cohort studies (iNET-CKD): a global network of chronic kidney disease cohorts.

Authors:  Thomas Dienemann; Naohiko Fujii; Paula Orlandi; Lisa Nessel; Susan L Furth; Wendy E Hoy; Seiichi Matsuo; Gert Mayer; Shona Methven; Franz Schaefer; Elke S Schaeffner; Laura Solá; Bénédicte Stengel; Christoph Wanner; Luxia Zhang; Adeera Levin; Kai-Uwe Eckardt; Harold I Feldman
Journal:  BMC Nephrol       Date:  2016-09-02       Impact factor: 2.388

View more
  1 in total

1.  Cortical and trabecular bone are equally affected in rats with renal failure and secondary hyperparathyroidism.

Authors:  Nikita M Bajwa; Cheryl P Sanchez; Richard C Lindsey; Heather Watt; Subburaman Mohan
Journal:  BMC Nephrol       Date:  2018-02-02       Impact factor: 2.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.